Product Reports Resources Pricing Login Book a demo

Abridge

Health Tech & Medtech · Pittsburgh, United States · Founded 2018

Machine learning technology that powers ability to highlight key points and integrate insights that help people understand their care

Valuation $5–10B
Revenue $100–500M
Headcount 500–1k
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Abridge and the history behind them.
Power Law Unicorn$1–10B valuation tier Thoroughbred$100M+ revenue
Knowledge graph
News IKS unit sells $10M stake in AI scribe startup Abridge Aug 6, 2026 News Abridge acquires YC-backed Altrina to add AI workflow automation Jul 28, 2026 News Abridge secures strategic investment from Eli Lilly, expands into payer and life sciences workflows Jun 11, 2026 Market map What if Google made this? Well, here's what happened Jun 8, 2026 Market map 1.5k+ AI Agents

Talent graph

Abridge's talent

Book a demo to see the people
Employees mapped 643 incl. 20 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 26 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

38 investors on Abridge's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 5 investors entered at this stage
Angel Investors Network
EMC
Venrock
Bessemer Venture Partners
KdT Ventures
Series A 12 investors entered at this stage
Union Square Ventures
Yoshua Bengio
Aneesh Chopra
Esther Dyson
The University of Pittsburgh Medical Center
UPMC Enterprises
Whistler Capital Partners
IKS Health
Wittington Ventures
Pillar VC
Zen Chu
Pillar Ventures
Series B+ 21 investors entered at this stage
Andreessen Horowitz
Kaiser Permanente Ventures
UC Investments
CVS Health Ventures
SV Angel
K-ventures
Khosla Ventures
Spark Capital
CapitalG
LifePoint Health
NVentures
California HealthCare Foundation
American College of Cardiology
Redpoint
Elad Gil
Eli Lilly
IVP
Mayo Clinic
Lightspeed Venture Partners
Mass General Brigham Ventures
SCAN Group

Ownership

Who owns Abridge

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.

22.5% Founders
  • Bessemer Venture Partners 14.5%

Some investors are hidden on this public profile. See the full cap table on Dealroom →

Global footprint

Where Abridge has talent and traffic

Workforce by country
3 countries with
team presence
🇺🇸 United States97.1%
🇨🇦 Canada2.3%
🇧🇷 Brazil0.4%
3 countries shown
Web traffic by country
300K monthly visits
across markets
🇺🇸 United States77.9%
🇮🇳 India5.2%
🇳🇬 Nigeria1.5%
🇨🇦 Canada1.1%
🇦🇺 Australia1.1%
Top 5 markets shown

Patent intelligence

$12k patent portfolio · 3 active families

Estimated portfolio value
$12k
<0.01% of valuation · 6426.3× smaller than top peer Dental Monitoring ($75M)
3 active patent families

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Abridge

An AI-synthesized read of the highest-engagement posts about Abridge on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Abridge on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles